 |
|
Home | Galena Biopharma Receives New Coverage from Analysts at Oppenheimer (GALE) |
 |
Galena Biopharma Receives New Coverage from Analysts at Oppenheimer (GALE)
|
 |
- November 26, 2013
-
Analysts at Oppenheimer began coverage on shares of Galena Biopharma (NASDAQ:GALE) in a research report issued to clients and investors on Tuesday, Analyst Ratings News reports. The firm set an “outperform” rating on the stock. Shares of Galena Biopharma (NASDAQ:GALE) opened at 3.67 on Tuesday. Galena Biopharma has a 52 week low of $1.48 and […]This article (Galena Biopharma Receives New Coverage from Analysts at Oppenheimer (GALE)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2013/11/26/galena-biopharma-receives-new-coverage-from-analysts-at-oppenheimer-gale/
|
 |
|
 |
|
 |
